Sanara MedTech (SMTI) Cash from Financing Activities (2010 - 2026)

Sanara MedTech (SMTI) has 15 years of Cash from Financing Activities data on file, last reported at -$475219.0 in Q1 2026.

• Quarterly Cash from Financing Activities fell 103.96% year-over-year to -$475219.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 111.91% YoY) and the FY2025 annual result came in at $8.9 million, down 48.82% from the prior year.
• Cash from Financing Activities fell to -$475219.0 in Q1 2026, from $139427.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $14.4 million in Q3 2024 to a low of -$2.5 million in Q2 2025.
• A 5-year average of $2.2 million and a median of -$144409.5 in 2022 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities tumbled 787.6% — and 2025, when it soared 1919.73%.
• Tracing SMTI's Cash from Financing Activities over 5 years: stood at -$304415.0 in 2022, then soared by 38.94% to -$185888.0 in 2023, then plunged by 546.06% to -$1.2 million in 2024, then soared by 111.61% to $139427.0 in 2025, then plunged by 440.84% to -$475219.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$475219.0 (Q1 2026), $139427.0 (Q4 2025), and -$774749.0 (Q3 2025), per Business Quant data.